 |
Alprostadil |
|---|---|
| Trade Name | |
| Orphan Indication | Severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated |
| USA Market Approval | USA |
| USA Designation Date | 1993-10-20 00:00:00 |
| Sponsor | Schwarz Pharma, Inc.;P.O. Box 2038;Milwaukee, Wisconsin, 53201 |
